Caplight Directory>Investors>Meneldor>Meneldor


Meneldor

Meneldor

Druten, Gelderlandmeneldor.nl

Overview

Meneldor is a venture capital firm founded in 2016. It invests in early-stage biotechnology and pharmaceutical companies that (re)develop (New) Biological or Chemical Molecular Entities, that have outstanding technology with strong IP, address significant unmet medical needs and commercially attractive markets. The firm thoroughly studies the science behind her potential portfolio companies and assesses key aspects such as IP, medical need, addressable markets, competition, risk, management, financial needs, and valuation.

Year Founded

2016

Portfolio Companies

4

Investments

CompanyDateStageLead
Tagworks PharmaceuticalsJun 2023Series ACo-investor
Hemispherian ASNov 2022Series ALead
Hemispherian ASMay 2022SeedLead
Tagworks PharmaceuticalsNov 2021SeedLead
LightOx LtdOct 2021SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersDruten, Gelderland
Year Founded2016

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.